Ali Raif Pharmaceuticals Tops Trademark Filings from Its R&D Center Results have been announced for Türkiye’s Top 250 Companies with the highest R&D spending. Turkishtime’s 2023 R&D 250 Research has ranked Ali Raif İlaç ranked first in the number of trademarks secured at its R&D Center. Turkishtime’s 11th annual cross-sector report on Turkish industry draws […]
- Login / Register
- 0 items - ₺0.00
- English
The Ali Raif Human Resources Directorate team won the third-place award in the 2022 TEGEP Education and Development Awards, organized by the Association of Education and Development Platform of Turkey. Since 2015, the TEGEP Education and Development Awards celebrates the best corporate education and development practices in Turkey to promote and recognize good practices. And […]
The economy and business portal Turkishtime published its ninth annual R&D 250 research. Based on 2021 data, Ali Raif became one of the “Highest R&D Spenders in Turkey” and placed fifth in all industries and fourth in the pharmaceutical industry in terms of the number of trademarks obtained in the R&D center. Ali Raif draws […]
August 2021 Fortune magazine continues to rank the largest companies in Turkey, just as it does in the United States, based on annual net turnover, exports, and profitability before tax, etc. Ali Raif İlaç continues its steady climb on the Fortune 500 List, which saw its 14th instalment this year. The Fortune 500 list includes […]
The Company Aims to Quadruple its Production Capacity Established in 1928, Ali Raif İlaç Sanayi has a deep-rooted history and an important place in the Turkish pharmaceutical industry with its 58 years of experience in the field. The company has now taken an important step in line with its growth targets and broke ground for […]
- 1
- 2